Tech Company Financing Transactions

Avid Radiopharmaceuticals Funding Round

AllianceBernstein, Alta Partners and BioAdvance Ventures participated in a $34.5 million Series D capital raise for Avid Radiopharmaceuticals. The round closed on 5/21/2009.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
Avid will use the proceeds primarily to fund the completion of development and, if approved, tocommercialize its Alzheimer's amyloid imaging compound, 18F-AV-45. Proceeds will also be used tocontinue Phase II clinical development of its Parkinson's disease imaging compound 18F-AV-133, as well as service general working capital needs.

Company Information

Company Status
Acquired or Merged
Mailing Address
3711 Market St. 710
Philadelphia, PA 19104
Email Address
Avid Radiopharmaceuticals, Inc. is a clinical-stage product-focused molecular imaging company that has assembled world-class expertise and IP in the field of molecular brain imaging. Avid has developed proprietary radiopharmaceuticals to image amyloid plaques and is currently testing these agents in clinical trials for the detection of Alzheimer's disease.
Avid Radiopharmaceuticals LinkedIn Company Profile
Social Media
Avid Radiopharmaceuticals Company Twitter Account
Company News
Avid Radiopharmaceuticals News
Avid Radiopharmaceuticals on Facebook
Avid Radiopharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Daniel Skovronsky
  Daniel Skovronsky LinkedIn Profile  Daniel Skovronsky Twitter Account  Daniel Skovronsky News  Daniel Skovronsky on Facebook
Chief Financial Officer
Richard Baron
  Richard Baron LinkedIn Profile  Richard Baron Twitter Account  Richard Baron News  Richard Baron on Facebook
Chief Scientific Officer
Franz Hefti
  Franz Hefti LinkedIn Profile  Franz Hefti Twitter Account  Franz Hefti News  Franz Hefti on Facebook
Vice President
Michael Pontecorvo
  Michael Pontecorvo LinkedIn Profile  Michael Pontecorvo Twitter Account  Michael Pontecorvo News  Michael Pontecorvo on Facebook
VP - Bus. Development
Alan Carpenter
  Alan Carpenter LinkedIn Profile  Alan Carpenter Twitter Account  Alan Carpenter News  Alan Carpenter on Facebook
VP - Manufacturing
Paul Kennedy
  Paul Kennedy LinkedIn Profile  Paul Kennedy Twitter Account  Paul Kennedy News  Paul Kennedy on Facebook



Browse more venture capital transactions:

Prev: 5/21/2009: Aragon Pharmaceuticals venture capital transaction
Next: 5/21/2009: CiDRA venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary